- 专利标题: T-cell modulatory multimeric polypeptides and methods of use thereof
-
申请号: US17749973申请日: 2022-05-20
-
公开(公告)号: US11505588B2公开(公告)日: 2022-11-22
- 发明人: Ronald D. Seidel, III , Rodolfo J. Chaparro
- 申请人: Cue Biopharma, Inc.
- 申请人地址: US MA Boston
- 专利权人: Cue Biopharma, Inc.
- 当前专利权人: Cue Biopharma, Inc.
- 当前专利权人地址: US MA Boston
- 代理机构: Bozicevic Field & Francis, LLP
- 代理商 Paula A. Borden
- 主分类号: C07K14/55
- IPC分类号: C07K14/55 ; A61K35/17 ; C07K14/47 ; C07K14/74 ; A61K9/00 ; C07K14/005 ; G01N33/50 ; A61K38/00 ; A61K39/00
摘要:
The present disclosure provides variant immunomodulatory polypeptides, and fusion polypeptides comprising the variant immunomodulatory peptides. The present disclosure provides T-cell modulatory multimeric polypeptides, and compositions comprising same, where the T-cell modulatory multimeric polypeptides comprise a variant immunomodulatory polypeptide of the present disclosure. The present disclosure provides nucleic acids comprising nucleotide sequences encoding the T-cell modulatory multimeric polypeptides, and host cells comprising the nucleic acids. The present disclosure provides methods of modulating the activity of a T cell; the methods comprise contacting the T cell with a T-cell modulatory multimeric polypeptide of the present disclosure.
公开/授权文献
信息查询